Related Experiment Video
Updated: Jul 11, 2026

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes
Published on: March 6, 2019
HLA and KIR polymorphisms affect NK-cell anti-tumor activity
Jakob R Passweg1, Bertrand Huard, Jean-Marie Tiercy
1Division of Hematology, University Hospital Geneva, CH-1211 Geneva 14, Switzerland.
Killer cell immunoglobulin-like receptors (KIRs) and human leukocyte antigen (HLA) gene combinations influence natural killer (NK) cell tolerance. Specific KIR-HLA genotypes may enable NK cells to eradicate acute myeloid leukemia blasts, suggesting potential for anti-tumor therapy.
Area of Science:
- Immunogenetics
- Cellular Immunology
- Cancer Immunology
Background:
- Natural killer (NK) cell tolerance is regulated by Killer cell immunoglobulin-like receptors (KIRs) and their Human Leukocyte Antigen (HLA) ligands.
- The high polymorphism of KIR and HLA genes leads to variable NK cell inhibition.
- Individual differences in NK cell tolerance can be influenced by specific KIR-HLA gene combinations.
Purpose of the Study:
- To explore the role of KIR-HLA gene combinations in NK cell tolerance.
- To investigate the potential of NK cells in eradicating acute myeloid leukemia (AML) blasts.
- To identify patient populations with favorable KIR-HLA genotypes for anti-tumor therapy clinical trials.
Main Methods:
- Analysis of KIR and HLA gene polymorphism.
- Assessment of NK cell tolerance mechanisms.
- Correlation of KIR-HLA genotypes with disease susceptibility and immune responses.
- Evaluation of NK cell activity against AML blasts in vitro and in vivo.
Main Results:
- Specific KIR-HLA gene combinations are associated with altered NK cell tolerance.
- Favorable KIR-HLA genotypes are linked to enhanced NK cell-mediated eradication of AML blasts.
- NK cell tolerance can be broken, potentially enabling anti-leukemic activity.
Conclusions:
- NK cell tolerance is a critical factor in immune responses and disease pathogenesis.
- Targeting KIR-HLA interactions may offer novel therapeutic strategies for acute myeloid leukemia.
- Clinical trials focusing on patients with specific KIR-HLA genotypes are warranted to assess NK cell-based anti-tumor therapies.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
